Papers
4
Total Citations
38
H-Index
3
About
Samuel L. Washington is a urologic oncologist whose research focuses on optimizing surgical outcomes and patient selection for prostate cancer treatment. His work centers on improving quality of life after radical prostatectomy, particularly through understanding how preoperative anatomical factors influence postoperative recovery. Washington’s most cited study (17 citations) demonstrated that preoperative membranous urethral length is a significant predictor of urinary incontinence following robot-assisted radical prostatectomy, providing surgeons with a valuable tool for patient counseling and surgical planning. He has also made important contributions to understanding benign prostate glandular tissue at surgical margins, with a 2013 study (13 citations) and a 2021 follow-up (6 citations) showing that such residual tissue does not lead to detectable PSA or biochemical recurrence—challenging prior assumptions about its clinical significance. More recently, Washington has explored optimal patient selection for high-intensity focused ultrasound (HIFU) in prostate cancer. His research bridges anatomical precision with practical clinical decision-making, directly impacting how urologists counsel patients and tailor surgical approaches. With a growing citation record, Washington is establishing himself as a thoughtful voice in prostate cancer outcomes research.
Research Focus
Key Achievements
Top Papers
- 1
- 2Benign Prostate Glandular Tissue at Radical Prostatectomy Surgical Margins13 citations · 2013
- 3
- 4